FDA Adverse Event Death Summary report: N

XACT CAROTID STENT SYSTEM

MDR report key: 2212306 · Received August 15, 2011

Report

Report Number
2024168-2011-05753
Event Type
Death
Date Received
August 15, 2011
Date of Event
July 26, 2011
Report Date
July 27, 2011
Manufacturer
AV-TEMECULA-CT
Product Code
NIM
PMA / PMN Number
P040038
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IN, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4). DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE EVENT, PATIENT AND DEVICE INFORMATION. THERE WAS NO REPORTED PRODUCT DEFICIENCY. THE REPORTED PATIENT EFFECTS OF HEMORRHAGE, DEATH, VISUAL DISTURBANCES AND WEAKNESS ARE KNOWN OBSERVED AND POTENTIAL ADVERSE EVENTS AS LISTED IN THE INSTRUCTIONS FOR USE. ALTHOUGH A CONCLUSIVE CAUSE FOR THE REPORTED ADVERSE PATIENT EFFECTS AND RELATIONSHIP TO THE DEVICE, IF ANY, COULD NOT BE DETERMINED, THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY WITH RESPECT TO MANUFACTURE, DESIGN OR LABELING.

Description of Event or Problem · 1

IT WAS REPORTED THAT APPROXIMATELY 50 MINUTES POST XACT STENT IMPLANTATION IN THE RIGHT INTERNAL CAROTID ARTERY (RICA), THE PATIENT EXPERIENCED LEFT UPPER AND LOWER EXTREMITY WEAKNESS AND RIGHT EYE BLINDNESS, WITH A SLIGHTLY DILATED RIGHT PUPIL. PER CT SCAN, AN ACUTE PARENCHYMAL HEMORRHAGE WAS SEEN ON THE RIGHT SIDE AND THE PATIENT WAS TRANSFERRED TO ANOTHER HOSPITAL. MEDICATIONS WERE PROVIDED; HOWEVER, THE CONDITION WORSENED AND ON (B)(6) 2011, THE PATIENT DIED. THERE WAS NO ADDITIONAL INFORMATION PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 XACT CAROTID STENT SYSTEM CAROTID STENT SYSTEM NIM AV-TEMECULA-CT 1051861

Patients

Seq Age Sex Outcome Treatment
1 78 YR Death EMBOLIC PROTECTION: EMBOSHIELD NAV6, BIVALIRUDIN.